Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Zhongyianke Biotech
company
About
Zhongyianke Biotech is a biotechnology firm.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $36M
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 2001
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Zhongyianke has launched a flu vaccine and is conducting clinical trials on four other human vaccines: a tetravalent influenza vaccine, a tetravalent meningococcal vaccine, a rabies vaccine, and a rubella vaccine. The company holds 14 China patents. In addition to its operations in Tianjin, the company has an R&D center in Beijing and a production facility in Liaoning Province.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$36M
Zhongyianke Biotech has raised a total of
$36M
in funding over 2 rounds. Their latest funding was raised on
Jul 5, 2019 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 5, 2019 | Series A | $36M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Zhongyianke Biotech is funded by 1 investors.
Huaige Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Huaige Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
